ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex Inc. ZYXI recently announced the Food and Drug Administration (“FDA”) clearance of its new TensWave device, which aligns perfectly with Zynex’s commitment to providing comprehensive pain ...
ENGLEWOOD, Colo., Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, ...
Zynex has been granted FDA clearance for its NexWave electrotherapy device, according to a Zynex news release. NexWave delivers three modalities of stimulation: interferential, neuromuscular ...
ENGLEWOOD, Colo., Feb. 6, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
Good afternoon, ladies and gentlemen. And welcome to the Zynex Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results